Potential mechanisms of interleukin-1 involvement in cerebral ischaemia

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 203-215

  Touzani, Omar ^a   Boutin, Hervé ^a   Chuquet, Julien ^a   Rothwell, Nancy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Central nervous system; Cerebral ischaemia; Interleukin 1

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NEUROPEPTIDE;

BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GERBIL; INFLAMMATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW;

EID: 0033387565     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00202-7     Document Type: Article

References (97)

1. Ali C., Nicole O., Docagne F., Lesne S., Nouvelot A., MacKenzie E.T., Buisson A., Vivien D. Evidence that IL-6 is selectively neuroprotective against excitotoxic-type of ischemic neuronal death. J. Cereb. Blood Flow Metab. 19:1999;S135. Suppl. 1, abstract.
2. Allan, S.M., Lawrence, C.B., Grundy, R.P., Stroemer, R.P., Rothwell, N.J., 1998. Sites and mechanisms of interleukin-1 action. In: Krieglstein, W.V.J., Oberpichler-Schwenk, H. (Eds.), Pharmacology of Cerebral Ischemia, Medpharm Scientific Publishers Stuttgart, Stuttgart, pp. 395-399.
3. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience. 43:1991;21-30.
4. Barone F.C., White R.F., Spera P.A., Ellison J., Currie R.W., Wang X.K., Feuerstein G.Z. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 29:1998;1937-1950.
5. Beasley D., Schwartz J.H., Brenner B.M. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:1991;602-608.
6. Benveniste E.N., Sparacio S.M., Norris J.G., Grenett H.E., Fuller G.M. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30:1990;201-212.
7. Betz A.L., Yang G.Y., Davidson B.L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15:1995;547-551.
8. Bhat R.V., DiRocco R., Marcy V.R., Flood D.G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P.C., Miller M. Increased expression of IL-1 beta converting enzyme in hippocampus after ischemia: selective localization in microglia. J. Neurosci. 16:1996;4146-4154.
9. Blasi F., Riccio M., Brogi A., Strazza M., Taddei M.L., Romagnoli S., Luddi A., D'Angelo R., Santi S., Costantino-Ceccarini E., Melli M. Constitutive expression of interleukin-1 beta (IL-1 beta) in rat oligodendrocytes. Biol. Chem. 380:1999;259-264.
10. Botchkina G.I., Meistrell M.E., Botchkina I.L., Tracey K.J. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol. Med. 3:1997;765-781.
11. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 240:1988;321-324.
12. Buisson A., Nicole O., Docagne F., Sartelet H., MacKenzie E.T., Vivien D. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. FASEB J. 12:1998;1683-1691.
13. Buttini M., Sauter A., Boddeke H.W. Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat. Mol. Brain Res. 23:1994;126-134.
14. Campbell V.A., Segurado R., Lynch M.A. Regulation of intracellular Ca2+ concentration by interleukin-1 beta in rat cortical synaptosomes: an age-related study. Neurobiol. Aging. 19:1998;575-579.
15. Chao C.C., Gekker G., Hu S.X., Kravitz F., Peterson P.K. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures. Biochem. Pharmacol. 56:1998;397-404.
16. Clark W.M. Cytokines and reperfusion injury. Neurology. 49:1997;S10-S14.
17. Das K.P., McMillian M.K., Bing G., Hong J.S. Modulatory effects of [Met5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures. J. Neuroimmunol. 62:1995;9-17.
18. Davies C.A., Loddick S.A., Toulmond S., Stroemer R.P., Hunt J., Rothwell N.J. The progression and topographic distribution of interleukin-1 beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19:1999;87-98.
19. De Simoni M.G., Sironi M., De Luigi A., Manfridi A., Mantovani A., Ghezzi P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J. Exp. Med. 171:1990;1773-1778.
20. De Simoni M.G., De Luigi A., Gemma L., Sironi M., Manfridi A., Ghezzi P. Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 265:1993;R739-R742.
21. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
22. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:1999;391-397.
23. French R.A., VanHoy R.W., Chizzonite R., Zachary J.F., Dantzer R., Parnet P., Bluthé R.-M., Kelley K.W. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J. Neuroimmunol. 93:1999;194-202.
24. Friedlander R.M., Gagliardini V., Hara H., Fink K.B., Li W., MacDonald G., Fishman M.C., Greenberg A.H., Moskowitz M.A., Yuan J. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185:1997;933-940.
25. Garcia J.H., Liu K.F., Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147:1995;1477-1486.
26. Garcia J.H., Liu K.-F., Ye Z.-R. Cytokines and reperfusion in ischemic stroke. Brain Pathol. 7:1997;1151-1161.
27. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18:1998;1283-1287.
28. Gayle D., Ilyin S.E., Miele M.E., Plata-Salaman C.R. Modulation of TNF-alpha mRNA production in rat C6 glioma cells by TNF-alpha, IL-1 beta, IL-6, and IFN-alpha: in vitro analysis of cytokine-cytokine interactions. Brain Res. Bull. 47:1998;231-235.
29. Gillespie M.T., Horwood N.J. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 9:1998;109-116.
30. Giulian D. Reactive glia as rivals in regulating neuronal survival. Glia. 7:1993;102-110.
31. Giulian D., Young D.G., Woodward J., Brown D.C., Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8:1988;709-714.
32. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13:1993;29-37.
33. Hagberg H., Gilland E., Bona E., Hanson L.A., Hahin-Zoric M., Blennow M., Holst M., McRae A., Soder O. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr. Res. 40:1996;603-609.
34. Hara H., Fink K., Endres M., Friedlander R.M., Gagliardini V., Yuan J., Moskowitz M.A. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab. 17:1997;370-375.
35. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., Moskowitz M.A. Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2007-2012.
36. Hartl R., Schurer L., Schmid-Schonbein G.W., del Zoppo G.J. Experimental antileukocyte interventions in cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1996;1108-1119.
37. Hartung H.P., Schafer B., Heininger K., Toyka K.V. Recombinant interleukin-1 beta stimulates eicosanoid production in rat primary culture astrocytes. Brain Res. 489:1989;113-119.
38. Hill J.K., Gunion-Rinker L., Kulhanek D., Lessov N., Kim S., Clark W.M., Dixon M.P., Nishi R., Stenzel-Poore M.P., Eckenstein F.P. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res. 820:1999;45-54.
39. Hillhouse E.W., Kida S., Iannotti F. Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1 beta in the cerebral cortex. Neurosci. Lett. 249:1998;177-179.
40. Hong L., Imeri L., Opp M.R., Postlethwaite A.E., Seyer J.M., Krueger J.M. Intercellular adhesion molecule-1 expression induced by interleukin (IL)-1 beta or an IL-1 beta fragment is blocked by an IL-1 receptor antagonist and a soluble IL-1 receptor. J. Neuroimmunol. 44:1993;163-170.
41. Iadecola, C., 1999. Inducible nitric oxide synthase gene expression and ischemic brain damage. In: Ruffolo, R.R., Feuerstein, G.Z., Hunter, A.J., Poste, G., Metcalf, B.W. (Eds.), Inflammatory cells and mediators in CNS disease, Harwood Academic Publishers, Philadelphia, PA, pp. 113-135.
42. Jander S., Kraemer M., Schroeter M., Witte O.W., Stoll G. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15:1995;42-51.
43. Katabami T., Shimizu M., Okano K., Yano Y., Nemoto K., Ogura M., Tsukamoto T., Suzuki S., Ohira K., Yamada Y. Intracellular signal transduction for interleukin-1 beta-induced endothelin production in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 188:1992;565-570.
44. Kohno K., Kurimoto M. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin. Immunol. Immunopathol. 86:1998;11-15.
45. Lechan R.M., Toni R., Clark B.D., Cannon J.G., Shaw A.R., Dinarello C.A., Reichlin S. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 514:1990;135-140.
46. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-14.
47. Licinio J., Wong M.L., Gold P.W. Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology. 129:1991;562-564.
48. Lin M.T., Kao T.Y., Jin Y.T., Chen C.F. Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res. Bull. 37:1995;595-598.
49. List J., Moser R.P., Steuer M., Loudon W.G., Blacklock J.B., Grimm E.A. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein). Cancer Res. 52:1992;1123-1128.
50. Liu T., McDonnell P.C., Young P.R., White R.F., Siren A.L., Hallenbeck J.M., Barone F.C., Feurestein G.Z. Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke. 24:1993;1746-1750.
51. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16:1996;932-940.
52. Loddick S.A., MacKenzie A., Rothwell N.J. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. NeuroReport. 7:1996;1465-1468.
53. Loddick S.A., Wong M.L., Bongiorno P.B., Gold P.W., Licinio J., Rothwell N.J. Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem. Biophys. Res. Commun. 234:1997;211-215.
54. Loddick S.A., Liu C., Takao T., Hashimoto K., De Souza E.B. Interleukin-1 receptors: cloning studies and role in central nervous system disorders. Brain Res. Brain Res. Rev. 26:1998;306-319.
55. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:1998;176-179.
56. Loughlin A.J., Woodroofe M.N. Inhibitory effect of interferon-gamma on LPS-induced interleukin 1 beta production by isolated adult rat brain microglia. Neurochem. Int. 29:1996;77-82.
57. Lovenberg T.W., Crowe P.D., Liu C., Chalmers D.T., Liu X.J., Liaw C., Clevenger W., Oltersdorf T., De Souza E.B., Maki R.A. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). J. Neuroimmunol. 70:1996;113-122.
58. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J. Neuroimmunol. 47:1993;73-81.
59. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58:1992;390-392.
60. Miura M., Zhu H., Rotello R., Hartwieg E.A., Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:1993;653-660.
61. Murray C.A., Clements M.P., Lynch M.A. Interleukin-1 induces lipid peroxidation and membrane changes in rat hippocampus: an age-related study. Gerontology. 45:1999;136-142.
62. Nawashiro H., Martin D., Hallenbeck J.M. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res. 778:1997;265-271.
63. Nawashiro H., Tasaki K., Ruetzler C.A., Hallenbeck J.M. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17:1997;483-490.
64. Norris J.G., Tang L.P., Sparacio S.M., Benveniste E.N. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 152:1994;841-850.
65. Osuka K., Suzuki Y., Watanabe Y., Dogan A., Takayasu M., Shibuya M., Yoshida J. Vasodilator effects on canine basilar artery induced by intracisternal interleukin-1 beta. J. Cereb. Blood Flow Metab. 17:1997;1337-1345.
66. Pantoni L., Sarti C., Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler. Thromb. Vasc. Biol. 18:1998;503-513.
67. Petito C.K., Chung M., Halaby I.A., Cooper A.J. Influence of the neuronal environment on the pattern of reactive astrocytosis following cerebral ischemia. Prog. Brain Res. 94:1992;381-387.
68. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:1992;243-246.
69. Relton J.K., Martin D., Thompson R.C., Russell D.A. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138:1996;206-213.
70. Rothwell N., Allan S., Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:1997;2648-2652.
71. Roux-Lombard P. The interleukin-1 family. Eur. Cytokine Network. 9:1998;565-576.
72. Sairanen T.R., Lindsberg P.J., Brenner M., Siren A.L. Global forebrain ischemia results in differential cellular expression of interleukin-1 beta (IL-1 beta) and its receptor at mRNA and protein level. J. Cereb. Blood Flow Metab. 17:1997;1107-1120.
73. Saito K., Suyama K., Nishida K., Sei Y., Basile A. Early increases in TNF-Alpha, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206:1996;149-152.
74. Schielke G.P., Yang G.Y., Shivers B.D., Betz A.L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18:1998;180-185.
75. Shibata M., Leffler C.W., Busija D.W. Recombinant human interleukin 1 alpha dilates pial arterioles and increases cerebrospinal fluid prostanoids in piglets. Am. J. Physiol. 259:1990;H1486-H1491.
76. Soriano S.G., Lipton S.A., Wang Y.F., Xiao M., Springer T.A., Gutierrez-Ramos J.C., Hickey P.R. Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann. Neurol. 39:1996;618-624.
77. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56:1998;149-171.
78. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:1995;3468-3474.
79. Stroemer R.P., Rothwell N.J. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 17:1997;597-604.
80. Stroemer R.P., Rothwell N.J. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 beta in the rat. J. Cereb. Blood Flow Metab. 18:1998;833-839.
81. Suzuki S., Tanaka K., Nagata E., Ito D., Dembo T., Fukuuchi Y. Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils. Neurosci. Lett. 262:1999;117-120.
82. Tacconi M.T. Neuronal death: is there a role for astrocytes? Neurochem. Res. 23:1998;759-765.
83. Tanaka M., McCarron R.M. The inhibitory effect of tumor necrosis factor and interleukin-1 on Ia induction by interferon-gamma on endothelial cells from murine central nervous system microvessels. J. Neuroimmunol. 27:1990;209-215.
84. Tilg H., Trehu E., Atkins M.B., Dinarello C.A., Mier J.W. Interleukin-6 (IL-6) as anti-inflammatory cytokines: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 83:1994;113-118.
85. Wang X., Yue T.L., Barone F.C., White R.F., Gagnon R.C., Feuerstein G.Z. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23:1994;103-114.
86. Wang X., Yue T.L., Young P.R., Barone F.C., Feuerstein G.Z. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15:1995;166-171.
87. Wang X., Barone F.C., Aiyar N.V., Feuerstein G.Z. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 28:1997;155-161.
88. Wilson R., Ainscough R., Anderson K., Baynes C., Berks M., Bonfield J., Burton J., Connell M., Copsey T., Cooper J. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature. 368:1994;32-38.
89. Xia L., Matera C., Ferin M., Wardlaw S.L. Interleukin-1 stimulates the central release of corticotropin-releasing hormone in the primate. Neuroendocrinology. 63:1996;79-84.
90. Yabuuchi K., Minami M., Katsumata S., Yamazaki A., Satoh M. An in situ hybridization study on interleukin-1 beta mRNA induced by transient forebrain ischemia in the rat brain. Brain Res. Mol. Brain Res. 26:1994;135-142.
91. Yamasaki Y., Matsuo Y., Matsuura N., Onodera H., Itoyama Y., Kogure K. Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats. Stroke. 26:1995;318-322.
92. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke. 26:1995;676-680.
93. Yang G.Y., Liu X.H., Kadoya C., Zhao Y.J., Mao Y., Davidson B.L., Betz A.L. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J. Cereb. Blood Flow Metab. 18:1998;840-847.
94. Yang Y., Quitschke W.W., Brewer G.J. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species. Brain Res. Mol. Brain Res. 60:1998;40-49.
95. Yang G.Y., Mao Y., Zhou L.F., Gong C., Ge H.L., Betz A.L. Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. Mol. Brain Res. 65:1999;143-150.
96. Zhai Q.H., Futrell N., Chen F.J. Gene expression of IL-10 in relationship to TNF-alpha, IL-1 beta and IL-2 in the rat brain following middle cerebral artery occlusion. J. Neurol. Sci. 152:1997;119-124.
97. Zhang Z., Chopp M., Goussev A., Powers C. Cerebral vessels express interleukin 1 beta after focal cerebral ischemia. Brain Res. 784:1998;210-217.